Jefferies Group LLC Increases Spectrum Pharmaceuticals, Inc. (SPPI) Price Target to $25.00


The brokerage currently has a "buy" rating on the biotechnology company's stock. Jefferies Group LLC's price objective would suggest a potential upside of 29.07% from the company's previous close.



from Biotech News